09:00 - 10:30 Session 3: The blast cell
- Integrated diagnosis and follow-up of acute lymphoblastic leukemia
A Porwit (Sweden)
- Integrated diagnosis and follow-up of acute myeloblastic leukemia
W Kern (Germany)
- Targeting leukemic cells: bi(multi)specifics and CAR-T cells
C Müller Tidow (Germany)
10:30 - 11:00 Coffee break
11:00 - 12:30 Session 4: CD5+ B-lymphocyte
Chair: TBC
- Integrated differential diagnosis and follow-up of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)
A Rawstron (United Kingdom)
- Altered pathways in the pathophysiology of CLL and MCL: towards guided therapy?
LM Fornecker (France)
- O01: Genomic and clinical characterization of Chronic lymphocytic leukemia patients with sub-microscopic IGH deletions: A study in 299 Indian patients
H Jain (India)
- O02: Integrated NGS testing and cfDNA analysis as an approach for aggregate tumor characterization and monitoring in a patient with aggressive lymphoma invading the central neural system
V Navrkalová (Czechia)
12:30 - 14:00 Lunch break
13:30 - 14:00 Round table session
14:00 - 15:30 Session 5: Lymphoma cells
Chair: TBC
- Integrated diagnosis of aggressive Non Hodgkin lymphoma (including pathology, FISH and molecular hematology)
A Porwit (Sweden)
- The Sternberg cell: a model of lymphocyte exhaustion
Speaker TBC
- The conundrum of T-cell lymphomas
O Tournilhac (France)
15:30 - 16:00 Coffee break
16:00 - 17:30 Session 6: The CML cell
Chair: TBC
- Pathophysiology of BCR-ABL applied to diagnosis
FX Mahon (France)
- When MRD monitoring leads to stop therapy
S Saussele (Germany)
- Patient testimonial
Speaker TBC
17:30 - 18:30 Session 7: Oral abstracts
- O03: Landscape of recurrent cytogenetic abnormalities in patients with multiple myeloma undergoing frontline autologous stem cell transplant as detected by cytogenetic microarray
Y Shestovska (United States)
- O04: Basic morphological tools and flowcytometry serving as the primary short cut in diagnosing Systemic Mastocytosis
N Elnagdy (Saudi Arabia)
- O05: TARGETED METABOLOMIC PROFILING OF AML PATIENTS: THE EFFECT OF CONDITIONING REGIMENS ON POST-TRANSPLANTATION COMPLICATIONS
A Hlavackova (Czechia)
- O06: Comprehensive NGS testing allows integrated assessment of individual patient prognosis in multiple myeloma
J Kotaskova (Czechia)
- O07: Detection of Minimal Residual Disease in Multiple Myeloma: Pre-enrichment Techniques to Maximise Sensitivity in Flow Cytometric Analysis
A O'Brien (Republic of Ireland)
Back